Tech Company Financing Transactions
Angiodroid Funding Round
Angiodroid, operating out of Savena (BO), secured $7.4 million in funding from CDP Venture Capital, 8a+ Investment and Air Liquide Venture Capital.
Transaction Overview
Company Name
Announced On
2/27/2023
Transaction Type
Venture Equity
Amount
$7,445,000
Round
Undisclosed
Investors
Proceeds Purpose
The company intends to use the funds to reinforce its international commercial presence, to forge new international partnerships with distributors and MedTech companies, and to support the development of Angiopulse, an IABP console for passive conterpulsation therapy.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
via Speranza 35
Savena (BO), 40068
IT
Savena (BO), 40068
IT
Phone
Website
Email Address
Overview
Innovation, Passion and Quality are our Core Values, and we pursue this aim every day. Contrast Induced Nephropathy has come to be the third cause leading to renal failure worldwide and this sometimes causes the lack of diagnosis in patients who risk this pathology. This is why at Angiodroid we are committed to create new solutions for healthcare through combining our clinical and engineering expertise with human insights to develop innovations that can improve the quality of people's lives. Our patented and CE marked exclusive automatic injection system for carbon dioxide angiography was specifically created for this purpose.
Management Team
Browse more venture capital transactions:
Prev: 2/27/2023: Colossyan venture capital transaction
Next: 2/27/2023: Skydio venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to record tech company VC transactions. VC investment data records reported here are sourced from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs